On 17 June 2026, ECHA hosted the first meeting of its Collaborative Platform on Alternatives to Animal Testing (CP-AAT), bringing together Member States, the European Commission, EU agencies, industry representatives, and public-private partnerships to strengthen collaboration and accelerate the regulatory uptake of alternative methods.

The platform, established as part of the European Commission's roadmap towards phasing out animal testing, identified four priority areas for its initial two-year work programme:
✅ QSARs and in silico methods for hazard assessment
✅ In vitro toxicokinetics and harmonised regulatory approaches
✅ Omics technologies (e.g., transcriptomics and metabolomics) for hazard identification and grouping
✅ New Approach Methodologies (NAMs) for nano- and advanced materials

A key message from the meeting was the need for structured collaboration, knowledge sharing, and alignment across stakeholders to accelerate innovation while avoiding duplication of effort.

As regulatory expectations continue to evolve, advancing scientifically robust alternatives will be essential to support safer chemicals management while reducing reliance on animal testing.

ECHA AnimalTesting ChemicalSafety REACH Sustainability Innovation InVitroTesting

SOURCE: https://lnkd.in/eZJ7wTw6